THE CHART TRIALS - BAYESIAN DESIGN AND MONITORING IN PRACTICE

被引:77
作者
PARMAR, MKB
SPIEGELHALTER, DJ
FREEDMAN, LS
机构
[1] UNIV CAMBRIDGE,MRC,INST PUBL HLTH,BIOSTAT UNIT,CAMBRIDGE CB2 2SR,ENGLAND
[2] NCI,DIV CANC PREVENT & CONTROL,BIOMETRY BRANCH,BETHESDA,MD 20892
关键词
D O I
10.1002/sim.4780131304
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
In this paper we describe the design and monitoring of two large randomized trials being conducted through the British Medical Research Council (MRC) Cancer Trials Office. In particular we discuss the issues involved in the design of the trials, specifying the null and alternative hypotheses and how the design has influenced the monitoring procedure used. From these two examples, and some other MRC experiences, we suggest some basic considerations which could be applied to many MRC and other trials.
引用
收藏
页码:1297 / 1312
页数:16
相关论文
共 17 条
[1]   THE WHAT, WHY AND HOW OF BAYESIAN CLINICAL-TRIALS MONITORING [J].
FREEDMAN, LS ;
SPIEGELHALTER, DJ ;
PARMAR, MKB .
STATISTICS IN MEDICINE, 1994, 13 (13-14) :1371-1383
[2]  
GROSSMAN J, 1994, IN PRESS STATISTICS, V13
[3]   AN AID TO DATA MONITORING IN LONG-TERM CLINICAL-TRIALS [J].
HALPERIN, M ;
LAN, KKG ;
WARE, JH ;
JOHNSON, NJ ;
DEMETS, DL .
CONTROLLED CLINICAL TRIALS, 1982, 3 (04) :311-323
[4]   ACTUAL GROWTH-RATE AND TUMOR-CELL PROLIFERATION IN HUMAN PULMONARY NEOPLASMS [J].
KERR, KM ;
LAMB, D .
BRITISH JOURNAL OF CANCER, 1984, 50 (03) :343-349
[5]  
LACHIN JM, 1981, CONTROLLED CLIN TRIA, V1, P13
[6]  
MACHIN D, 1987, STATISTICAL TABLES D
[7]  
PARMAR MKB, 1993, STAT MED, V12, P495
[8]  
PARMAR MKB, UNPUB WHY WHEN DO WE
[9]   A CONTROLLED CLINICAL-TRIAL OF MISONIDAZOLE IN THE RADIOTHERAPY OF PATIENTS WITH CARCINOMA OF THE BRONCHUS [J].
SAUNDERS, MI ;
ANDERSON, P ;
DISCHE, S ;
MARTIN, WMC .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (3-4) :347-350
[10]   RADIOTHERAPY EMPLOYING 3 FRACTIONS IN EACH DAY OVER A CONTINUOUS PERIOD OF 12 DAYS [J].
SAUNDERS, MI ;
DISCHE, S .
BRITISH JOURNAL OF RADIOLOGY, 1986, 59 (701) :523-525